Startups
Ryne Bio is a biotechnology company that aims to develop and commercialize potent disease-modifying treatments for neurological disorders. The company’s lead program is an iPSC dopamine neuron progenitor (RNDP-) targeting Parkinson’s Disease. They leverage induced pluripotent stem cell (iPSC) technology to enable precision manufacture of therapeutically relevant human neurons.
However, they are a unique company that focuses on developing off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorders.
However, they are a unique company that focuses on developing off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorders.
Overview
Location
United States, California, San Diego
Employees
1-10
Total raised
$4M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 14, 2023 | Ryne Biotechnology Snags $4M Grant | San Diego-based Ryne Biotechnology, a company developing stem cell technology to treat neurological disorders, says it has received a $4M grant from the California Institute for Regenerative Medicine (CIRM). The company said it will use the... |
| Ryne Biotechnology | “Ryne Biotechnology” | |
| Ryne Biotechnology | “Private Site” |
Reviews 0
FAQ about Ryne Biotechnology
How much funding has Ryne Biotechnology raised?
Ryne Biotechnology has raised $4M in total across 1 funding round.
What has the press written about Ryne Biotechnology?
Parsers VC has collected 4 articles mentioning Ryne Biotechnology, among them “Ryne Biotechnology Snags $4M Grant” (Feb 14, 2023) and “Ryne Biotechnology”.
Is Ryne Biotechnology still active?
Yes, Ryne Biotechnology is active; its latest activity on Parsers VC dates from Feb 14, 2023.